29
1 Supporting Information for: 2 Sulfated quaternary amine lipids: a new class of inverse charge 3 zwitterlipids 4 5 Vincent J. Venditto, a Aaron Dolor, a Aditya Kohli, b Stefan Salentinig, c Ben J. Boyd c and Francis C. Szoka, Jr. a,b 6 7 a Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California 8 San Francisco, San Francisco, CA 94143. b The UC Berkeley-UCSF Graduate Program in Bioengineering, 9 University of California Berkeley, Berkeley, CA 94720. c Drug Delivery, Disposition and Dynamics, 10 Monash Insititute of Pharmaceutical Sciences, Monash University, Victoria 3052, Australia. 11 12 This work was supported by NIH EB003008. VJ Venditto was funded by a grant from the National Institutes of 13 Allergy and Infectious diseases of the National Institutes of Health under Award Number F32AI095062. A 14 Dolor was funded by a fellowship from the National Science Foundation Graduate Research Fellowship 15 Program. The content is solely the responsibility of the authors and does not necessarily represent the official 16 views of the National Institutes of Health or the National Science foundation. 17 18 Address correspondence and reprint requests to Dr. Francis C. Szoka, Jr., Departments of Bioengineering and 19 Therapeutic Sciences and Pharmaceutical Chemistry, School of Pharmacy, University of California, San 20 Francisco, San Francisco, California, 94143-0912. Tel: (415) 476-3895; Fax: (415) 476-0688; E-mail: 21 [email protected]. Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2014

Supporting Information for: zwitterlipids Sulfated

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Supporting Information for: zwitterlipids Sulfated

1 Supporting Information for:

2 Sulfated quaternary amine lipids: a new class of inverse charge

3 zwitterlipids

4

5 Vincent J. Venditto,a Aaron Dolor,a Aditya Kohli,b Stefan Salentinig,c Ben J. Boydc and Francis C. Szoka, Jr.a,b

6

7 aDepartment of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California

8 San Francisco, San Francisco, CA 94143. bThe UC Berkeley-UCSF Graduate Program in Bioengineering,

9 University of California Berkeley, Berkeley, CA 94720. cDrug Delivery, Disposition and Dynamics,

10 Monash Insititute of Pharmaceutical Sciences, Monash University, Victoria 3052, Australia.

11

12 This work was supported by NIH EB003008. VJ Venditto was funded by a grant from the National Institutes of

13 Allergy and Infectious diseases of the National Institutes of Health under Award Number F32AI095062. A

14 Dolor was funded by a fellowship from the National Science Foundation Graduate Research Fellowship

15 Program. The content is solely the responsibility of the authors and does not necessarily represent the official

16 views of the National Institutes of Health or the National Science foundation.

17

18 Address correspondence and reprint requests to Dr. Francis C. Szoka, Jr., Departments of Bioengineering and

19 Therapeutic Sciences and Pharmaceutical Chemistry, School of Pharmacy, University of California, San

20 Francisco, San Francisco, California, 94143-0912. Tel: (415) 476-3895; Fax: (415) 476-0688; E-mail:

21 [email protected].

Electronic Supplementary Material (ESI) for ChemComm.This journal is © The Royal Society of Chemistry 2014

Page 2: Supporting Information for: zwitterlipids Sulfated

1 Table of Contents

2 Experimental Section page3 1. Materials………………………………………………………………………………………34 2. General synthetic scheme……………………………………………………………………..35 3. Chemical characterization…………………………………………………………………….46 4. Elemental analysis…………………………………………………………………………….67 5. Differential scanning calorimetry……………………………………………………………..68 6. Transmission electron microscopy……………………………………………………………79 7. Small angle X-ray scattering measurements…………………………………………………..7

1011 Tables and Figures.12 Table S1: Elemental Analysis of AS lipids………………………………………………………..813 Figure S1: BrPrOSO3-DIPEA (1) 1H……………………………………………………………...914 Figure S2: BrPrOSO3-DIPEA (1) 13C……………………………………………………………1015 Figure S3: DOAS (3a) 1H………………………………………………………………………..1116 Figure S4: DOAS (3a) 13C……………………………………………………………………….1217 Figure S5: DSAS 1H……………………………………………………………………………..1318 Figure S6: DSAS 13C…………………………………………………………………………….1419 Figure S7: DPAS 1H……………………………………………………………………………..1520 Figure S8: DPAS 13C…………………………………………………………………………….1621 Figure S9: DMAS (3a) 1H………………………………………………………………………..1722 Figure S10: DMAS (3a) 13C………………………………………………………………..……1823 Figure S11: DLAS 1H……………………………………………………………………………1924 Figure S12: DLAS 13C…………………………………………………………………………...2025 Figure S13: DCAS 1H…………………………………………………………………………....2126 Figure S14: DCAS 13C…………………………………………………………………………...2227 Figure S15: SAXS scattering profile for DOAS with increasing temperature…………………..2328 Figure S16: DOAS scattering profiles with increasing temperatures……………………………2329 Figure S17: Change in lamellar spacing with temperature for DOAS…...……………………...2430 Figure S18: DOAS data and fit for thickness pair distance distribution fuction at 20 oC……….2431 Figure S19: pt(r) calculated from DOAS SAXS data at 20 oC…………………………………..2532 Figure S20: DOAS data and fit for thickness pair distance distribution function at 80 oC……...2533 Figure S21: pt(r) calculated from DOAS SAXS data at 20 oC…………………………………..2634 Figure S22: Electron density within the bilayer at 20 oC and 80 oC……………………………..2635 Figure S23: SAXS scattering profile for DMAS with increasing temperature……………...…..2736 Figure S24: DMAS scattering profiles with increasing temperatures…………………………...2737 Figure S25: Change in particle size by DLS with increasing temperature…….………………...2838 Figure S26: Determination of polydispersity by DLS with increasing temperature…………….2939 Figure S27: Differential scanning calorimetry of DMAS in the presence of kosmotropic 40 salts as compared to DMPC……………………………………………………..304142434445

2

Page 3: Supporting Information for: zwitterlipids Sulfated

1 Experimental Section

2 1. Materials.

3 NMR measurements were performed on a Bruker (Billerica, MA) 300MHz Avance system and

4 analyzed using TopSpin software. Chemical shifts are expressed as parts per million using

5 tetramethylsilane or CDCl3 solvent peaks as internal standards. MALDI-TOF measurements were

6 performed on a Bruker Daltonics MicroFlex LT system (Billerica, MA). High Performance flash

7 chromatography (HPFC) was carried out using a Grace Reveleris Flash System (Columbia, MD) with

8 prepacked silica gel columns. Elemental analysis was performed by the Microanalytical Laboratory at

9 the University of California Berkeley using an ICP Optima 7000 DV instrument. Zeta potential and size

10 measurements were carried out using a Nano-ZS Dynamic Light Scattering Instrument from Malvern

11 (Westborough, MA). Differential Scanning Calorimetry (DSC) measurements were obtained using a

12 high temperature MC-DSC 4100 calorimeter from Calorimetry Sciences Corp. (Lindonk, UT).

13 Fluorescence measurements were made on a FLUOstar plate reader from BMG Labtech (Durham, NC)

14 with excitation at 485 nm and emission at 518 nm. TEM images were obtained using an FEI Tecnai 12

15 transmission electron microscope at the University of California Berkeley Robert D. Ogg Electron

16 Microscope Laboratory or the University of California, San Francisco Molecular Electron Microscopy

17 Lab.

18

19 2. General Synthetic Scheme.

20 Lipids were prepared in a two-step synthesis (Scheme 1) starting with the acylation of 3-

21 (dimethylamino)-1,2-propanediol as previously reported (Kohli, 2012). Synthesis of 1-bromo-3-

22 propanesulfate (1) was performed by stirring 1 mmol of 1-bromo-3-propanol at 0.2 M in DCM as 4

23 mmol sulfurtrioxide-pyridine complex (45%) and 1 mmol diisopropyl ethylamine was added. The

3

Page 4: Supporting Information for: zwitterlipids Sulfated

1 reaction was then heated to 40 °C overnight under nitrogen. The reaction was concentrated and taken up

2 in DCM to afford a solid, which was removed by filtration and the filtrate purified by silica gel flash

3 chromatography (0-10% methanol in DCM). The product eluted as the 1-bromo-3-propanesulfate –

4 diisopropyl ethylamine salt in a 1:1 ratio as determined by NMR.

5 The diacyl tertiary amine lipid (2a-f) (1 mmol) was then quaternized with 1-bromo-3-

6 propanesulfate (1) (3.5 mmol) and 2 mmol diisopropyl ethylamine in dimethylformamide at 0.15 M. The

7 reactions were heated to 60 °C overnight under nitrogen. A precipitate formed in the reactions with

8 saturated lipid tails (distearoyl (3b), dipalmitoyl (3c), dimyristoyl (3d), dilauryl (3e) and dicapryloyl

9 (3f)) and these solutions were then heated to 80 °C for 2 hours before cooling to room temperature. The

10 precipitate reformed and was filtered and washed with DMF to yield a white solid. Quaternization of the

11 unsaturated lipid (dioleoyl (3a)) was performed in the same manner, but did not result in a precipitate.

12 The reaction mixture was concentrated and taken up in DCM and purified by silica gel flash

13 chromatography (0-10% methanol in chloroform with 0.1% NH4OH).

14

15 3. Chemical Characterization.

16 1-bromo-3-propanesulfate – diisopropyl ethylamine salt (1). Yield (74%). 1H NMR (CDCl3):

17 δ 1.44 (d, 6H, DIPEA), 1.51 (d, 6H, DIPEA), 1.51 (d, 6H, DIPEA), 1.53 (t, 3H, DIPEA), 2.24 (tt, 2H),

18 2.24 (tt, 2H), 3.13 (m, 2H, DIPEA), 3.54 (t, 2H), 3.69 (m, 2H, DIPEA), 4.19 (t, 2H). 13C NMR (CDCl3):

19 δ 12.4 (DIPEA), 17.3 (DIPEA), 18.6 (DIPEA), 30.2, 32.7, 42.8 (DIPEA), 54.5 (DIPEA), 65.3.

20 DOAS (3a). Yield: 45%. 1H NMR (CDCl3): δ 0.89 (t, 6H), 1.29 (m, 40H), 1.59 (m, 4H), 2.02 (m,

21 8H), 2.26 (m, 2H), 2.32 (m, 4H), 3.21 (s, 3H), 3.28 (s, 3H), 3.49 (m, 2H), 3.68 (t, 2H), 3.94 (dd, 1H),

22 4.12 (t, 2H), 4.51 (dd, 1H), 5.35 (m, 4H), 5.64 (m, 1H). 13C NMR (CDCl3): δ 14.12, 22.68, 24.70, 24.80,

23 27.22, 27.24, 29.10, 29.16, 29.20, 29.22, 29.28, 29.32, 29.34, 29.54, 29.78, 31.91, 33.89, 34.19, 51.18,

4

Page 5: Supporting Information for: zwitterlipids Sulfated

1 51.63, 63.37, 65.81, 129.70, 130.05, 172.80, 173.23. MALDI-TOF calculated for [C44H83NO8S] (m/z):

2 785.58, observed: 787.39. Elemental analysis for [C44H83NO8S]: C, 67.22; H, 10.64; N, 1.78; S, 4.08.

3 Found: C, 67.22; H, 10.90; N, 1.68; S, 4.33.

4 DSAS (3b). Yield: 42%. 1H NMR (CDCl3:MeOD (20:1)): δ 0.76 (t, 6H), 1.14 (m, 56H), 1.49 (m,

5 4H), 2.06 (m, 2H), 2.24 (m, 4H), 2.99 (s, 3H), 3.03 (s, 3H), 3.49 (m, 2H), 3.57 (t, 2H), 3.93 (dd, 1H),

6 4.00 (t, 2H), 4.34 (dd, 1H), 5.48 (m, 1H). 13C NMR (CDCl3): δ 13.60, 22.31, 24.30, 24.38, 25.28, 28.77,

7 29.00, 29.16, 29.33, 31.57, 33.49, 33.75, 50.51, 51.25, 57.60, 62.95, 63.54, 63.83, 65.18, 172.65, 173.23.

8 MALDI-TOF calculated for [C44H87NO8S] (m/z): 789.62, observed: [M+H] 791.16. Elemental analysis

9 for [C44H87NO8S]: C, 66.79; H, 11.21; N, 1.77; S, 4.05. Found: C, 66.58; H, 11.54; N, 1.74; S, 4.65.

10 Note: Elemental analysis of sulfur is believed to be high due to free sulfate.

11 DPAS (3c). Yield: 71%. 1H NMR (CDCl3:MeOD (20:1)): δ 0.79 (t, 6H), 1.17 (m, 48H), 1.52 (m,

12 4H), 2.09 (m, 2H), 2.26 (m, 4H), 3.01 (s, 3H), 3.05 (s, 3H), 3.51 (m, 2H), 3.61 (t, 2H), 3.95 (dd, 1H),

13 4.03 (t, 2H), 4.35 (dd, 1H), 5.51 (m, 1H). 13C NMR (CDCl3): δ 13.95, 22.57, 22.85, 24.56, 24.63, 29.00,

14 29.04, 29.22, 29.26, 29.43, 29.55, 29.57, 29.59, 31.82, 33.74, 34.03, 50.82, 51.34, 57.98, 63.22, 63.79,

15 63.90, 64.22, 64.39, 65.48, 172.86, 173.41. MALDI-TOF calculated for [C40H79NO8S] (m/z): 733.55,

16 observed: [M+H] 734.88. Elemental analysis for [C40H79NO8S]: C, 65.35; H, 10.97; N, 1.91; S, 4.36.

17 Found: C, 65.17; H, 11.33; N, 1.95; S, 4.79.

18 DMAS (3d). Yield: 71%. 1H NMR (CDCl3:MeOD (20:1)): δ 0.82 (t, 6H), 1.20 (m, 40H), 1.53

19 (m, 4H), 2.14 (m, 2H), 2.29 (m, 4H), 3.05 (s, 3H), 3.10 (s, 3H), 3.56 (m, 2H), 3.67 (t, 2H), 3.99 (dd, 1H),

20 4.06 (t, 2H), 4.38 (dd, 1H), 5.53 (m, 1H). 13C NMR (CDCl3): δ 13.89, 22.51, 22.81, 24.50, 24.57, 28.97,

21 29.19, 29.35, 29.49, 31.76, 33.68, 33.97, 50.66, 51.22, 63.09, 63.61, 63.88, 64.47, 65.37, 172.75, 173.31.

22 MALDI-TOF calculated for [C36H71NO8S] (m/z): 677.49, observed: [M+H] 678.59. Elemental analysis

5

Page 6: Supporting Information for: zwitterlipids Sulfated

1 for [C36H71NO8S]: C, 63.68; H, 10.69; N, 2.06; S, 4.72. Found: C, 63.52; H, 10.92; N, 1.98; S, 5.35.

2 Note: Elemental analysis of sulfur is believed to be high due to free sulfate.

3 DLAS (3e). Yield: 69%. 1H NMR (CDCl3:MeOD (20:1)): δ 0.77 (t, 6H), 1.15 (m, 32H), 1.50 (m,

4 4H), 2.07 (m, 2H), 2.24 (m, 4H), 3.00 (s, 3H), 3.05 (s, 3H), 3.49 (m, 2H), 3.60 (t, 2H), 3.95 (dd, 1H),

5 4.01 (t, 2H), 4.35 (dd, 1H), 5.49 (m, 1H). 13C NMR (CDCl3): δ13.79, 22.44, 22.76, 24.42, 24.50, 28.85,

6 28.89, 29.05, 29.07, 29.10, 29.24, 29.26, 29.37, 29.40, 31.67, 33.59, 33.88, 50.57, 51.10, 63.03, 63.53,

7 63.81, 64.30, 65.31, 172.70, 173.29. MALDI-TOF calculated for [C32H63NO8S] (m/z): 621.43,

8 observed: [M+H] 622.91. Elemental analysis for [C32H63NO8S]: C, 61.80; H, 10.21; N, 2.25; S, 5.16.

9 Found: C, 61.52; H,9.85; N,2.13; S, 5.03.

10 DCAS (3f). Yield: 65%. 1H NMR (CDCl3): δ0.90 (t, 6H), 1.29 (m, 24H), 1.60 (m, 4H), 2.27 (m,

11 2H), 2.35 (m, 4H), 3.21 (s, 3H), 3.29 (s, 3H), 3.70 (m, 3H), 3.96 (dd, 1H), 4.13 (t, 3H), 4.51 (dd, 1H),

12 5.64 (m, 1H). 13C NMR (CDCl3): δ14.10, 22.70, 24.74, 24.84, 29.19, 29.36, 29.49, 31.91, 33.94, 34.25,

13 51.10, 51.64, 63.39, 63.61, 63.84, 64.56, 65.84, 172.83, 173.25. MALDI-TOF calculated for

14 [C28H55NO8S] (m/z): 565.37, observed: [M+H] 566.72. Elemental analysis for [C28H55NO8S]: C, 59.44;

15 H, 9.80; N, 2.48; S, 5.67. Found: C, 59.32; H, 9.67; N, 2.46; S, 5.63.

16

17 4. Elemental analysis.

18 Dry lipid samples (10 mg) were submitted to the Microanalytical Laboratory at the University of

19 California Berkeley for elemental analysis determinations using an ICP Optima 7000 DV instrument.

20

21 5. Differential Scanning Calorimetry.

22 DSC experiments were based upon a protocol described in Huang and Szoka.{Huang:2008iy}

23 Lipids films were prepared in glass tubes from a 20 mg/mL stock solution in 25% methanol in

6

Page 7: Supporting Information for: zwitterlipids Sulfated

1 chloroform by concentrating the lipids under vacuum. The lipid films were then rehydrated at 20 mM in

2 10 mM HEPES buffer containing either 150 mM NaCl, 1M NaCl, 1M NaI or 1 M NaClO4.

3 In all experiments, the lipids were heated to 90 °C for 10 min and sonicated with heating for 10

4 minutes, then 250 uL of lipid was transferred to a reusable Hestelloy sample ampoule using a glass

5 syringe. Data were collected over a range of 10-110 °C at 1 °C/min with the relevant buffer as the

6 reference. The CpCalc 2.1 software package was used to convert the raw data into a molar heat capacity.

7 The data was then exported to Excel and GraphPad Prism for processing. Samples were scanned through

8 a heat-cool-heat cycle and data was collected from the second heating cycle.

9

10 6. Transmission electron microscopy.

11 A 2.0 uL drop of liposomes were adsorbed for 60 s on glow-discharged carbon-coated copper

12 grid (Ted Pella, Redding, CA) and water was wicked off. Then, 2 microliters of a 1% uranyl acetate

13 negative stain solution was added and left to stain for 60 s and wicked off. The grid was then washed

14 with double deionized water three times and the water was removed by wicking. Grids were imaged

15 with an FEI Tecnai T12 TEM (FEI company, Hillsboro, OR) at 120kV. Data were acquired with a 4 x 4

16 Gatan UltraScan CCD camera (Gatan, Pleasanton, CA).

17

18 7. Small angle X-ray scattering measurements.

19 Pure lipids for SAXS were prepared at 20 mM in 10mM HEPES buffer containing 150 mM

20 NaCl. Aqueous phases were heated to 90 oC and added to lipid, vortexed and sonicated in a sonicating

21 bath for 10 min. SAXS data were measured on the SAXS/WAXS beamline at the Australian

22 Synchrotron. Buffer was drawn into a fixed position flowthrough quartz capillary, mounted in a brass

23 block fitted with a thermocouple, to allow for background measurements and the temperature ramped

7

Page 8: Supporting Information for: zwitterlipids Sulfated

1 from ‘nominal’ 20 oC to about 80 oC, and a 10 min equilibration at each temperature prior to acquisition

2 of scattering for 5 sec. The camera (Pilatus 1M) was positioned 3252 mm from the sample, with X-ray

3 energy selected at 11 keV. Modeling of scattering data calculations were performed using GIFT.

4

5 Table S1: Elemental analysis of AS lipids.

6

C% H% N% S%Expected 59.44 9.80 2.48 5.67Observed 59.32 9.67 2.46 5.63

Expected 61.80 10.21 2.25 5.16Observed 61.52 9.85 2.13 5.35

Expected 63.68 10.69 2.06 4.72Observed 63.52 10.92 1.98 5.35

Expected 65.35 10.97 1.91 4.36Observed 65.17 11.33 1.95 4.79

Expected 66.79 11.21 1.77 4.05Observed 66.58 11.54 1.74 4.65

Expected 67.22 10.64 1.78 4.08Observed 67.22 10.9 1.68 4.33

DCAS

DLCS

DMCS

DPCS

DSCS

DOAS

7

8

9

10

8

Page 9: Supporting Information for: zwitterlipids Sulfated

1 Figure S1: BrPrOSO3–DIPEA (1) – 1H NMR

2

3

49

Page 10: Supporting Information for: zwitterlipids Sulfated

1 Figure S2: BrPrOSO3-DIPEA (1) – 13C NMR

2

3

410

Page 11: Supporting Information for: zwitterlipids Sulfated

1 Figure S3: DOAS (3a) – 1H NMR

2

11

Page 12: Supporting Information for: zwitterlipids Sulfated

1 Figure S4: DOAS (3a) – 13C NMR

2

3

412

Page 13: Supporting Information for: zwitterlipids Sulfated

1 Figure S5: DSAS (3b) – 1H NMR

2

3

413

Page 14: Supporting Information for: zwitterlipids Sulfated

1 Figure S6: DSAS (3b) – 13C NMR

2

3

414

Page 15: Supporting Information for: zwitterlipids Sulfated

1 Figure S7: DPAS (3c) – 1H NMR

2

315

Page 16: Supporting Information for: zwitterlipids Sulfated

1 Figure S8: DPAS (3c) – 13C NMR

2

3

416

Page 17: Supporting Information for: zwitterlipids Sulfated

1 Figure S9: DMAS (3d) – 1H NMR

2

3

417

Page 18: Supporting Information for: zwitterlipids Sulfated

1 Figure S10: DMAS (3d) – 13C NMR

2

3

18

Page 19: Supporting Information for: zwitterlipids Sulfated

1 Figure S11: DLAS (3e) – 1H NMR

2

3

419

Page 20: Supporting Information for: zwitterlipids Sulfated

1 Figure S12: DLAS (3e) – 13C NMR

2

3

20

Page 21: Supporting Information for: zwitterlipids Sulfated

1 Figure S13: DCAS (3f) – 1H NMR

2

3

421

Page 22: Supporting Information for: zwitterlipids Sulfated

1 Figure S14: DCAS (3f) – 13C NMR

2

3

22

Page 23: Supporting Information for: zwitterlipids Sulfated

1 Figure S15: SAXS scattering profile for DOAS (3a) with increasing temperature (background subtracted).

2

1

10

100

1000

10000

0.00 0.05 0.10 0.15 0.20 0.2520

30

4050

6070

Inte

nsity

q (Å-1)

Tem

perature (°C)

Scattering profiles for DOCS with increasing temperature (background subtracted)

3

4 Figure S16: DOAS (3a) scattering profile with increasing temperature.

5

DOCS scattering profiles with increasing temperature

q (Å-1)

0.05 0.10 0.15 0.20 0.25

Tem

pera

ture

(°C

)

30

40

50

60

700.1 1 10 100

23

Page 24: Supporting Information for: zwitterlipids Sulfated

1 Figure S17: Change in lamellar spacing with temperature for DOAS (3a).

2

Change in lamellar spacing with temperature for DOCS

Temperature

10 20 30 40 50 60 70 80

Latti

ce S

paci

ng (Å

)

43.5

44.0

44.5

45.0

45.5

46.0

46.5

3

4 Figure S18: DOAS (3a) SAXS data and fit for the thickness pair distance distribution function at 20 oC. 5 Structure factor for the lamellar phase (modified Caille Theory) number of bilayer: 200, bilayer spacing: 46.0 6 Å, Caille parameter: 0.14 Å-1.7

89

24

Page 25: Supporting Information for: zwitterlipids Sulfated

1 Figure S19: pt(r) calculated from SAXS data in Figure S18.

2

3

4 Figure S20: DOAS (3a) SAXS data and fit for the thickness pair distance distribution function at 80 oC. 5 Structure factor for the lamellar phase (modified Caille Theory) number of bilayer: 76.3, bilayer spacing: 43.8 6 Å, Caille parameter: 0.14 Å-1.

7

89

25

Page 26: Supporting Information for: zwitterlipids Sulfated

1 Figure S21: pt(r) calculated from SAXS data in Figure S20.

234 Figure S22: Electron density within the bilayer thickness calculated via deconvolution of the pt(r) functions.

56789

10111213

26

Page 27: Supporting Information for: zwitterlipids Sulfated

1 Figure S23: SAXS scattering profile for DMAS (3d) with increasing temperature.

2

1e-1

1e+0

1e+1

1e+2

1e+3

1e+4

1e+5

0.050.10

0.150.20

0.2520

30

40

50

60

70

80

Inte

nsity

q (Å -1)

Tem

pera

ture

(°C)

Scattering profiles for DMCS with increasing temperature (background subtracted)

3456 Figure S24: DMAS (3a) scattering profiles with increasing temperature.

7

DMCS scattering profiles with increasing temperature

q (Å-1)

0.05 0.10 0.15 0.20 0.25

Tem

pera

ture

(°C

)

30

40

50

60

700.1 1 10 100

27

Page 28: Supporting Information for: zwitterlipids Sulfated

1 Figure S25: Determination of particle size by dynamic light scattering with increasing temperature. The high 2 polydispersity index of these measurements are shown in Figure S26.3

4

Particle size dependence with temperature

Temperature in DLS (°C)

20 30 40 50 60 70 80

Zave

rage

radi

us (n

m)

200

250

300

350

400

450

5001000

2000

3000

4000

5000

DOCSDMCS

Temperature in DLS (°C)

30 40 50

Zave

rage

radi

us (n

m)

200

250

300

350

Cou

nts

220000

240000

260000

280000

300000

320000

340000

DOCS ZaveDOCS Counts

5

6

28

Page 29: Supporting Information for: zwitterlipids Sulfated

1 Figure S26: Determination of polydispersity by dynamic light scattering with increasing temperature for 2 DMAS.

3

Polydispersity of DMCS dispersion with increasing temperature

Temperature in DLS (°C)

10 20 30 40 50 60 70 80 90

Pol

ydis

pers

ity In

dex

0.2

0.4

0.6

0.8

1.0

4

5

6 Figure S27: Differential scanning calorimetry of DMAS in the presence of kosmotropic salts as compared to 7 DMPC.

8

DMAS

40 60 80

150 mM NaCl1M NaCl1M NaI1M NaClO41M NH4Cl1M (NH4)2SO41M Na2SO4

Temperature (oC)

DMAS

76 78 80 82

150 mM NaCl

1M NaCl1M NH4Cl

1M (NH4)2SO4

1M Na2SO4

78.3

77.978.0

79.2

78.4

Temperature (oC)

DMPC

26 28 30 32

150 mM NaCl1M NH4Cl

26.026.4

1M (NH4)2SO4

1M Na2SO4 27.127.9

Temperature (oC)

DMPC

20 30 40

150 mM NaCl1M NH4Cl1M (NH4)2SO41M Na2SO4

Temperature (oC)

Peak Max Peak Max

29